WANA (Aug 23) – Iran has announced the development of more than 600 cell-based products, marking major advances in the treatment of cancer, chronic wounds, and other hard-to-treat conditions.

 

With the rising global challenges of incurable diseases, an aging population, and limited medical resources, experts say regenerative medicine has emerged as a groundbreaking field offering new hope to millions of patients worldwide.

 

Iran, after more than 16 years of sustained investment, has now positioned itself as a regional leader in regenerative medicine and one of the advancing nations globally in this field.

 

According to officials, the country’s progress has been driven by strong academic capacity, support for strategic research, and the growth of knowledge-based companies.

 

Today, more than 160 biotech firms in Iran are actively engaged in regenerative medicine, collectively registering over 600 products and 365 patents.

 

Among the most notable achievements are cell therapy techniques for hard-to-treat diseases and advances in tissue engineering, which are transforming healthcare approaches domestically. Approved cell-based drugs are already being used in Iran to treat conditions such as graft-versus-host disease and vitiligo.

 

Clinical trials are also underway for innovative treatments targeting leukemia, gastric cancer, and surgical wound repair, raising hopes for less invasive and more effective therapies.

 

These scientific and technological strides are anchored in robust infrastructure across major cities, including Tehran, Isfahan, Shiraz, Tabriz, and Mashhad, which serve as hubs for product development, clinical research, and training of new specialists in regenerative medicine.

 

Looking ahead, Iran has set its sights on bioprinting of living tissues, expanding gene therapy applications, and building a national stem cell donor network as strategic priorities to strengthen scientific independence and technological sovereignty in healthcare.

 

In broader terms, Iran’s journey in regenerative medicine reflects what officials describe as a synergy of national determination, indigenous knowledge, and global vision—a narrative of self-reliance aimed at creating a healthier future for its people.

Drug for cancer. Social media/ WANA News Agency